| Literature DB >> 29540615 |
Stefan Roth1,2, Vikramjeet Singh1,2, Steffen Tiedt1,2, Lisa Schindler1,2, Georg Huber3, Arie Geerlof3, Daniel J Antoine4, Antoine Anfray5, Cyrille Orset5, Maxime Gauberti5, Antoine Fournier5, Lesca M Holdt6, Helena Erlandsson Harris7, Britta Engelhardt8, Marco E Bianchi9, Denis Vivien5, Christof Haffner1, Jürgen Bernhagen1,2, Martin Dichgans1,2, Arthur Liesz10,2.
Abstract
Stroke induces a multiphasic systemic immune response, but the consequences of this response on atherosclerosis-a major source of recurrent vascular events-have not been thoroughly investigated. We show that stroke exacerbates atheroprogression via alarmin-mediated propagation of vascular inflammation. The prototypic brain-released alarmin high-mobility group box 1 protein induced monocyte and endothelial activation via the receptor for advanced glycation end products (RAGE)-signaling cascade and increased plaque load and vulnerability. Recruitment of activated monocytes via the CC-chemokine ligand 2-CC-chemokine receptor type 2 pathway was critical in stroke-induced vascular inflammation. Neutralization of circulating alarmins or knockdown of RAGE attenuated atheroprogression. Blockage of β3-adrenoreceptors attenuated the egress of myeloid monocytes after stroke, whereas neutralization of circulating alarmins was required to reduce systemic monocyte activation and aortic invasion. Our findings identify a synergistic effect of the sympathetic stress response and alarmin-driven inflammation via RAGE as a critical mechanism of exacerbated atheroprogression after stroke.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29540615 DOI: 10.1126/scitranslmed.aao1313
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956